In: Schizophrenia Bulletin, 2017, vol. 43, no. 5, p. 1027-1035
|
In: Personal and Ubiquitous Computing, 2015, vol. 19, no. 2, p. 335-353
|
In: International Journal of Neuropsychopharmacology, 2016, vol. 19, no. 8, p. -
|
In: European Archives of Psychiatry and Clinical Neuroscience, 2015, vol. 265, no. 4, p. 273-280
|
In: Journal of Gambling Studies, 2015, vol. 31, no. 1, p. 295-297
|
In: Psychiatric Quarterly, 2015, vol. 86, no. 2, p. 153-168
|
In: ADHD Attention Deficit and Hyperactivity Disorders, 2015, vol. 7, no. 3, p. 199-209
|
In: European Archives of Psychiatry and Clinical Neuroscience, 2015, vol. 265, no. 8, p. 719-734
|
In: Schizophrenia Bulletin, 2018, vol. 44, no. 1, p. 147-157
|
In: PROTEOMICS – Clinical Applications, 2020, vol. 14, no. 5, p. 1900117
Alpha‐synuclein (α‐syn) dopaminylation can lead to the death of dopaminergic neurons in the brain and is a risk factor of Parkinson's disease (PD). This study aims to examine whether such a posttranslational modification (PTM) is presented in human blood plasma. Experimental Design: In vitro reaction simulation between α‐syn and dopamine (DA) is conducted to study the biochemical...
|